UNSPSC 51183702: Netoglitazone

This classification denotes an anti-diabetic agent with the molecular formula C21H16FNO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) QOV2JZ647A, chemically known as 2,4-thiazolidinedione, 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)- but more generally known as netoglitazone, which bears US NIH Compound Identifier 204109. The term NETOGLITAZONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16., No. 1.2002, List 47).

UNSPSC 51183702 Netoglitazone is a Commodity code covering a specific pharmaceutical active ingredient, but state and local procurement activity under it occurs primarily through cooperative purchasing vehicles soliciting broad generic pharmaceutical portfolios rather than this drug in isolation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions. MMCAP solicits manufacturers to supply comprehensive pharmaceutical product lines with detailed National Drug Codes, SKUs, and packaging configurations; successful vendors must maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and carry substantial insurance including $5,000,000 commercial general liability and $2,000,000 network security and privacy liability. Evaluation weights pricing competitiveness (75 percent) and compliance with administrative requirements, EDI capability, and pricing structure flexibility (collectively 25 percent).

Geographic activity centers on the upper Midwest and Pacific Northwest through the MMCAP cooperative, which serves multiple states including Minnesota and Oregon. The representative recent opportunity is MMCAP's RFP S1070000015802, posted January 20, 2026, with a response deadline of March 26, 2026 and contract effectiveness of July 1, 2026. The solicitation applies no disclosed set-aside designations and does not identify specific budget ranges, though vendors must accept a 3 percent administrative fee on all contract purchases and face performance penalties of $200 to $1,500 per violation for reporting delays, missed onboarding timelines, or improper class-of-trade denials. Contract term runs two years for new responders with optional extensions at MMCAP's discretion; incumbent responders' amendments align with existing agreements through June 30, 2028.